Health Catalyst Inc. (HCAT) PT Lowered to $20 at Citi
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Price: $1.53 -6.13%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Citi analyst Daniel Grosslight lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $20.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Canaccord Downgrades Health Catalyst Inc. (HCAT) to Hold
- Alibaba (9988:HK) (BABA) PT Raised to HK$188.70 at Macquarie
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB147.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
